StockNASDAQ · US · USDHealthcare · Medical Care Facilities
$ASTH
Astrana Health, Inc.
Astrana Health operates an integrated healthcare delivery platform that helps providers participate in value-based care and coordinate care for patients covered by Medicare, Medicaid, health maintenance organizations, and private insurance, as well as some non-insured patients. As of December 31, 2025, its network includes more than 20,000 contracted physicians and coordinates care for approximately 1.6 million patients. Astrana has three segments. Care Partners builds and manages provider networks, including independent practice associations, accountable care organizations, and licensed health plans that take on varying levels of healthcare cost risk. Care Delivery provides care through more than 60 locations, including primary and specialty clinics, a hospital, and ancillary services such as imaging, labs, urgent care, and a specialty pharmacy. Care Enablement provides technology and administrative services to its own operations and outside providers and payers. Astrana earns money through capitation payments, risk pool settlements and incentives, management fees, fee-for-service care, and other revenue. It is headquartered in Alhambra, California.
Needham reaffirmed its Buy rating for Astrana Health and increased its price target to $45 from $41, suggesting a 15.4% upside from the Nov 5 close of $39.01, according to the firm.
Astrana Health (ASTH) reported Q3 2026 results with record revenue of $1.02B (+7% YoY), net income of $20.3M (+1,782% YoY), and adjusted EBITDA of $77.2M (+13% YoY). For the nine months, revenue was $2.96B (+33% YoY), net income $47.1M (+186% YoY), and free cash flow $105.4M. The company provided guidance for Q4 and full-year 2026.
Astrana Health (ASTH), a healthcare management company, reported Q2 revenue growth of 49% YoY and expects 25% growth in FY2026. The company has a market cap of $1.9B, trades at $38/share, and aims to reduce its leverage ratio. Analysts project EPS to triple this year and continue growing. The author suggests a covered call strategy for investing in ASTH.
via TradingView
ASTH sentiment & insider activity
Recent ASTH coverage spans financial news, market movers and earnings.
What's driving ASTH
Analyst upgrade may attract buying interest and support price toward the new target.
Alignment Healthcare (ALHC) will add Astrana Health to its Medicare Advantage network in seven California counties from January 2027, expanding access to 3,000 PCPs and 6,500 specialists. This move supports ALHC's growth strategy in key markets.
AlphAI scores every news story that mentions ASTH with an AI model for sentiment and relevance, and aggregates insider trades from Astrana Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Needham reaffirmed its Buy rating for Astrana Health and increased its price target to $45 from $41, suggesting a 15.4% upside from the Nov 5 close of $39.01, according to the firm.
Astrana Health (ASTH) reported Q3 2026 results with record revenue of $1.02B (+7% YoY), net income of $20.3M (+1,782% YoY), and adjusted EBITDA of $77.2M (+13% YoY). For the nine months, revenue was $2.96B (+33% YoY), net income $47.1M (+186% YoY), and free cash flow $105.4M. The company provided guidance for Q4 and full-year 2026.
Astrana Health (ASTH), a healthcare management company, reported Q2 revenue growth of 49% YoY and expects 25% growth in FY2026. The company has a market cap of $1.9B, trades at $38/share, and aims to reduce its leverage ratio. Analysts project EPS to triple this year and continue growing. The author suggests a covered call strategy for investing in ASTH.
Alignment Healthcare (ALHC) will add Astrana Health to its Medicare Advantage network in seven California counties from January 2027, expanding access to 3,000 PCPs and 6,500 specialists. This move supports ALHC's growth strategy in key markets.
Verda Healthcare, a Medicare Advantage plan, partners with AstranaCare Partners to serve Pan-Asian, Hispanic, and Arab American communities in Texas and Arizona. Astrana Health (NASDAQ: ASTH) brings expertise in value-based care. Verda aims to improve healthcare for underrepresented groups.
Astrana Health (ASTH) stock has risen 35.1% in six months, reaching $37.03. The company, formerly Apollo Medical Holdings, reported 40.2% revenue growth and 11.6% EPS growth over five years. However, its return on invested capital has declined. The stock trades at 11.1× forward P/E. Analysts debate its valuation and potential for new investments.
Alignment Healthcare (ALHC) announced its Medicare Advantage plan will expand to three new California counties in 2027, adding Hoag and Astrana Health to its provider network, totaling 25 counties served.
Astrana Health notified the SEC of a data breach caused by a social engineering attack, potentially exposing patient, provider, and corporate data. The company is investigating and has taken remedial actions. Astrana, with 2025 revenue of $3.2B, stated the incident is material but does not expect it to affect its financial condition or operations. The company has cyber insurance but cannot guarantee it will cover all losses.
Astrana Health (ASTH) shares fell 5.5% after disclosing a cybersecurity incident and data breach at its subsidiary, adding to existing pressures from a securities-law investigation and Medicare regulatory concerns. The stock is volatile, down 33.3% from its 52-week high, and up 31.7% year-to-date. Investors are assessing the long-term impact of potential Medicare Advantage reforms on the company's margins.
Astrana Health ASTH fell 7% premarket after reporting a 'material' cybersecurity incident at its subsidiary, Astrana Health Management. The breach involved unauthorized access to private/confidential data via social engineering. The company is investigating and stated the incident won't materially impact its financials, as of Sept. 22.